Genmab A/S (GMAB) Financials: Revenue & Earnings

GMAB$51.37—
BiotechnologyLarge CapHigh Quality
Compare
Market cap$31.20BEnterprise value—Revenue (TTM)$4.3BMarket positionTop 25%

Score

37
Bearish
Value
29
Quality
63
Growth
20

Financial Summary

Genmab A/S (GMAB) last printed $51.37. Equity value is $31.20B. Trailing earnings multiple 43.17. The revenue row is reported history.

Financials

2016201720182019202020212022202320242025
$1.82B$2.37B$3.03B$5.37B$10.11B$8.42B$14.51B$16.47B$21.53B$3.72B

Genmab A/S (GMAB) Financials: Revenue & Earnings

GMAB price $51.37 —

Ticker
GMAB
Price
$51.37
Change
—
Market cap
$31.20B
P/E
43.17
Forward P/E
40.20
Dividend yield
0.00%
Beta
0.65
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
37
Value
29
Quality
63
Growth
20

Stocklytics score rationale: value 29, quality 63, growth 20.

Insights · Forecast · Financials · Learn

Stocklytics home · Screener